Lv1
30 积分 2026-01-07 加入
Phase III trial of telitacicept in SLE
2个月前
已完结
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of the Anti-IFNAR1 Monoclonal Antibody QX006N: A First-in-Human Single Ascending Dose Study in Healthy Chinese Volunteers
2个月前
已完结
Efficacy and Safety of Ivarmacitinib, a Selective JAK1 Inhibitor, in Patients With Active Ankylosing Spondylitis: Results From an Adaptive Seamless Phase 2/3 Trial
2个月前
已完结
Ivarmacitinib for Moderate to Severe Atopic Dermatitis in Adults and Adolescents
2个月前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
2个月前
已完结
Methotrexate for treating rheumatoid arthritis
2个月前
已完结
Contemporary approaches to the management of rheumatoid arthritis: precision and progress
2个月前
已完结
The role of NLRP3 inflammasome in the pathogenesis of rheumatic disease
2个月前
已完结
Population Pharmacokinetics of the TNF‐α and IL‐17A Dual‐Variable Domain Antibody ABT‐122 in Healthy Volunteers and Subjects With Psoriatic or Rheumatoid Arthritis: Analysis of Phase 1 and 2 Clinical Trials
2个月前
已完结
Positive phase II trial of IL-17A–IL-17F-targeting nanobody sonelokimab for PsA
2个月前
已完结
皖公网安备34019202002308
